We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

104 hedge funds and large institutions have $417M invested in Cardiovascular Systems, Inc. in 2016 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

116% more capital invested

Capital invested by funds: $193M → $417M (+$224M)

70% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 10

68% more call options, than puts

Call options by funds: $601K | Put options by funds: $358K

20% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 30

7% more funds holding

Funds holding: 97104 (+7)

Holders
104
Holders Change
+7
Holders Change %
+7.22%
% of All Funds
2.77%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.05%
New
17
Increased
36
Reduced
30
Closed
10
Calls
$601K
Puts
$358K
Net Calls
+$243K
Net Calls Change
+$514K
Name Holding Trade Value Shares
Change
Change in
Stake
CCM
1
Camber Capital Management
Massachusetts
$75.3M +$64M +4,100,000 New
Wellington Management Group
2
Wellington Management Group
Massachusetts
$50M -$4.62M -295,868 -10%
CIP
3
Champlain Investment Partners
Vermont
$27.8M -$4.15M -265,425 -15%
First Manhattan
4
First Manhattan
New York
$25.5M -$717K -45,900 -3%
Vanguard Group
5
Vanguard Group
Pennsylvania
$23.4M +$2.42M +155,207 +14%
BC
6
Broadfin Capital
New York
$22.6M -$3.67M -235,162 -16%
GIM
7
Granahan Investment Management
Massachusetts
$20.6M +$2M +128,275 +13%
BFA
8
BlackRock Fund Advisors
California
$18.9M +$1.11M +70,775 +7%
FCM
9
Frontier Capital Management
Massachusetts
$15.6M -$350K -22,380 -3%
D.E. Shaw & Co
10
D.E. Shaw & Co
New York
$15M +$2.13M +136,065 +20%
BIT
11
BlackRock Institutional Trust
California
$14.8M +$802K +51,329 +7%
Fidelity Investments
12
Fidelity Investments
Massachusetts
$11.4M +$1.87M +120,000 +24%
State Street
13
State Street
Massachusetts
$9.6M +$325K +20,773 +4%
NRC
14
North Run Capital
Massachusetts
$9.36M
Point72 Asset Management
15
Point72 Asset Management
Connecticut
$7.42M +$4.71M +301,624 +295%
Northern Trust
16
Northern Trust
Illinois
$7.2M +$264K +16,924 +5%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$4.02M +$63.2K +4,045 +2%
Thrivent Financial for Lutherans
18
Thrivent Financial for Lutherans
Minnesota
$3.76M
Manulife (Manufacturers Life Insurance)
19
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$3.26M -$1.11M -70,956 -29%
BIM
20
Bogle Investment Management
Massachusetts
$2.93M -$1.73M -110,439 -41%
PVI
21
Pura Vida Investments
New York
$2.67M +$2.27M +145,289 New
Bank of New York Mellon
22
Bank of New York Mellon
New York
$2.62M +$101K +6,437 +5%
TCIM
23
TIAA CREF Investment Management
New York
$2.47M +$534K +34,213 +34%
BIM
24
BlackRock Investment Management
Delaware
$2.32M +$213K +13,621 +12%
MPI
25
Mairs & Power Inc
Minnesota
$2.23M -$1.95M -125,000 -51%

CSII Hedge Fund Activity: Q2 2016 in Review

104 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2016, worth a combined $417M — up 116% from $193M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CSII positions and 10 closed out — a net gain of 7 holders — while 36 added to existing stakes and 30 trimmed.

The largest buyer was Camber Capital Management, opening a new position worth an estimated $64M. The largest seller was Wellington Management Group, cutting an estimated $4.62M.

  • 104 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2016, up from 97 in Q1 2016.
  • Funds reported $417M of Cardiovascular Systems, Inc. stock for Q2 2016, up 116% quarter-over-quarter.
  • 17 funds opened new Cardiovascular Systems, Inc. positions in Q2 2016 and 10 closed out, a net change of +7 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2016 was Camber Capital Management, an estimated $64M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2016 was Wellington Management Group, an estimated $4.62M sold.

Based on aggregated 13F filings for Q2 2016.